argenx SE Operating Expenses 2011-2026 | ARGX

Annual Operating Expenses argenx SE

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
2.27 B	1.69 B	1.17 B	888 M	543 M	293 M	-	-	-	-	-	8.91 M	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
2.27 B	8.91 M	981 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
Acer Therapeutics ACER	24.6 M	-	2.71 %	$ 14 M	USA
Acorda Therapeutics ACOR	206 M	-	-24.86 %	$ 820 K	USA
ADMA Biologics ADMA	101 M	$ 15.57	-5.89 %	$ 3.71 B	USA
AgeX Therapeutics AGE	10.1 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	210 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	66.5 M	-	-	$ 26.5 M	USA
AbCellera Biologics ABCL	292 M	$ 3.58	-1.38 %	$ 1.07 B	Canada
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Anika Therapeutics ANIK	51.6 M	$ 14.19	-1.18 %	$ 208 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
Akero Therapeutics AKRO	80.2 M	-	-	$ 3.67 B	USA
Aptorum Group Limited APM	20.7 M	$ 0.82	-0.73 %	$ 4.47 M	China
Akouos AKUS	86.8 M	-	0.23 %	$ 488 M	USA
Alpine Immune Sciences ALPN	88.2 M	-	-	$ 2.17 B	USA
AlloVir ALVR	65.4 M	-	4.14 %	$ 49.1 M	USA
Apellis Pharmaceuticals APLS	948 M	$ 20.24	1.91 %	$ 2.55 B	USA
Ampio Pharmaceuticals AMPE	9.57 M	-	-11.43 %	$ 502 K	USA
ANI Pharmaceuticals ANIP	127 M	$ 75.6	-1.22 %	$ 1.46 B	USA
Applied Therapeutics APLT	74.5 M	-	-	$ 8.42 M	USA
Autolus Therapeutics plc AUTL	145 M	$ 1.5	-8.28 %	$ 383 M	Britain
Aravive ARAV	80 M	-	-13.39 %	$ 1.45 M	USA
Adverum Biotechnologies ADVM	140 M	-	-	$ 86.2 M	USA
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
Athersys ATHX	79.8 M	-	3.77 %	$ 22.4 M	USA
ARCA biopharma ABIO	88.1 M	-	1052.0 %	$ 415 M	USA
AVEO Pharmaceuticals AVEO	44.9 M	-	-	$ 521 M	USA
Axsome Therapeutics AXSM	99.1 M	$ 159.87	-2.57 %	$ 7.95 B	USA
BridgeBio Pharma BBIO	304 M	$ 65.73	-1.22 %	$ 12.6 B	USA
Brainstorm Cell Therapeutics BCLI	31.7 M	-	-2.5 %	$ 5.88 M	USA
BioDelivery Sciences International BDSI	106 M	-	-4.8 %	$ 255 M	USA
Acasti Pharma ACST	24.4 M	-	4.01 %	$ 150 M	Canada
BeiGene, Ltd. BGNE	390 M	-	0.49 %	$ 251 B	Cayman-islands
Bellicum Pharmaceuticals BLCM	28.5 M	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	152 M	-	-7.31 %	$ 87 M	USA
Equillium EQ	50.6 M	$ 1.79	2.29 %	$ 62.2 M	USA
CureVac N.V. CVAC	88.9 M	-	-	$ 867 M	Germany
Aeterna Zentaris AEZS	23 M	-	5.93 %	$ 314 M	Canada
Bellerophon Therapeutics BLPH	22.4 M	-	-74.18 %	$ 955 K	USA
BioLineRx Ltd. BLRX	28.1 M	$ 2.72	-3.31 %	$ 908 M	Israel
BioMarin Pharmaceutical BMRN	1.47 B	$ 60.54	0.18 %	$ 11.6 B	USA
Burford Capital Limited BUR	106 M	$ 8.26	-1.31 %	$ 1.36 B	Britain
Cabaletta Bio CABA	74.7 M	$ 3.2	-6.71 %	$ 3.74 M	USA
AIkido Pharma AIKI	29.7 M	-	1.93 %	$ 17.4 M	USA
Agenus AGEN	46 M	$ 2.93	-8.44 %	$ 1.05 M	USA
Ayala Pharmaceuticals AYLA	29.8 M	-	-	$ 7.46 M	Israel
Capricor Therapeutics CAPR	49.3 M	$ 25.74	0.94 %	$ 689 M	USA